Collaborative Robots (Cobots) Market is projected to be worth USD 18 billion by 2030 | #collaborative Robots (Cobots) Market

Economics and Trade

Collaborative Robots (Cobots) Market is projected to be worth USD 18 billion by 2030

Given their flexibility and price to functionality ratio, cobots represent an ideal entry-level, automation model for both small and established companies, which do not intend to make very heavy large investments in automation

Contract Manufacturing Market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030 | #contract Manufacturing Market

Economics and Trade

Contract Manufacturing Market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world.

Cell Therapies and Encapsulation Technologies Market is projected to be over USD 3.7 billion by 2030 | #cell Therapies and Encapsulation Technologies Market

Economics and Trade

Cell Therapies and Encapsulation Technologies Market is projected to be over USD 3.7 billion by 2030

More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the globe, claims Roots Analysis

Cancer Biomarkers Market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030 | #cancer Biomarkers Market

Economics and Trade

Cancer Biomarkers Market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions

Blood-Brain Barrier (BB Penetrating Drugs Market is estimated to be worth USD 900 million in 2030 | #blood-Brain Barrier (BB Penetrating Drugs Market

Economics and Trade

Blood-Brain Barrier (BBB) Penetrating Drugs Market is estimated to be worth USD 900 million in 2030

Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries